Skip to content
stockresearch.app
WST/History

West Pharmaceutical Services (WST) valuation history

Within its usual range

As of

WST's EV/Sales of 8.4x is higher than 63% of its available weekly readings from the last five years.

EV/Sales weekly history4.1×7.6×11.1×14.6×Shading: 5-year middle halfMedian 7.9×8.4×202120232025
Share EV/Sales history
Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/Sales at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

WST year-end valuation history
Reading dateEV/Sales5-year rank
6.5×22%
8.5×38%
8.8×50%
6.0×37%
13.1×97%
11.8×98%
6.3×100%
4.3×40%
4.8×84%
4.3×Short history

Loading related research…

About this history

What is WST's current EV/Sales?
WST's EV/Sales of 8.4x is higher than 63% of its available weekly readings from the last five years.
What is WST's five-year median EV/Sales?
The median, or middle weekly reading, is 7.9× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Source: SEC company filings and weekly market prices. Multiples use the previous twelve months of financial results. Updated .

Read the valuation methodology